Get your Emails warmed up and ready to send

Build sender reputation and reach more inboxes with automated email warmup.

Warm up your emails

Starting at $49/month

Start Warming Up

Patrick de Boer

CEO Aiosyn @Aiosyn

Amsterdam, NL
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jul 2021 — Present

CEO Aiosyn @Aiosyn

Aiosyn develops precision pathology solutions to boost the efficiency and quality of histopathologic assessment in breast cancer and chronic kidney diseases powered by artificial intelligence. We develop CE/FDA certified medical devices and integrate these into standard pathology workflows. Aiosyn supports pharma/CROs with quantitative histopathology as part of research and clinical studies to improve the reproducibility of biomarker scoring, find new (predictive) biomarkers for therapy efficacy and optimise the design of clinical trials.

SKILLS

HealthcareTechnology TransferBiotechnologyManagementStart-UpsMolecular BiologyMedical DevicesR&DClinical ResearchPharmaceutical IndustryResearchManagement ConsultingScienceLifesciencesBusiness PlanningLife SciencesBusiness Strategy

ABOUT PATRICK DE BOER

Serial entrepreneur in AI-based digital health technologies for diagnostics and…

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.